Propolis: Research, Apitherapy and Clinical Applications
Apis · 15.06.2026 · 3 (1) · 38-41
DOI: 10.62949/03907046.4931149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Apis, online erschienen am 15.06.2026. Verfasst von José Maurício Sforcin. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The literature shows that propolis has been widely used in the treatment of inflammatory diseases and wound healing for centuries.
Objective
The aim of this paper is to present the key findings from in vitro and in vivo assays, as well as clinical trials, involving propolis.
Methods
Publications related to research conducted in vitro using different cell cultures, and in vivo using mice and other experimental animals, were examined. Clinical trials involving propolis were also analysed.
Results
Literature revealed the significant antimicrobial, anti-inflammatory and antitumor effects of propolis, either on its own or when combined with medicines, indicating its efficiency and usefulness. The pharmacological activities of propolis demonstrate its potential as an adjuvant or alternative to conventional drugs, either on its own or in combination with drugs commonly used to treat various diseases.
Conclusion
The in vitro and in vivo assays allowed for the conducting of clinical trials, which confirmed the benefits of propolis for human health.
Zitieren
APA
Sforcin, J. M. (2026). Propolis: Research, Apitherapy and Clinical Applications. Apis, 3(1), 38-41. https://doi.org/10.62949/03907046.4931149
Vancouver
Sforcin JM. Propolis: Research, Apitherapy and Clinical Applications. Apis. 2026;3(1):38-41. doi:10.62949/03907046.4931149
BibTeX
@article{Sforcin2026,
author = {Sforcin, José Maurício},
title = {Propolis: Research, Apitherapy and Clinical Applications},
journal = {Apis},
year = {2026},
volume = {3},
number = {1},
pages = {38--41},
doi = {10.62949/03907046.4931149}
}
EUVIMED